En Español     CJ Australia
LOGIN OR REGISTER

EULAR
By
6.15.22 3:31PM

8 Noteworthy COVID-19 Studies from EULAR 2022

Learn about the groundbreaking COVID research presented at The European Alliance of Associations for Rheumatology conference — and find out what it means for our patient community.

Joseph CoeBy
6.15.22 1:40PM

Patient Perspective: Notable Rheumatic Disease Studies at EULAR

Learn about the research updates and medical news for rheumatic diseases from the European Congress of Rheumatology 2022 — and hear from one patient advocate about why this matters for our community.

Barbara BrodyBy
6.3.22 4:01PM

What’s Preventing Rheumatic Disease Patients from Hitting Treatment Targets?

Study explores what’s holding patients back from making medication changes, like adding or switching DMARDs, to reach treatment goals.

Barbara BrodyBy
6.3.22 9:41AM

New Study Explores Why Language Nuances Matter in Good Rheumatic Care

Researchers explore how language plays a role in patient-doctor communication among Hispanic/Latinx patients with rheumatoid arthritis in the United States and Puerto Rico.

Barbara BrodyBy
6.2.22 9:11AM

Researchers Shed Light on What Information Is Top Priority for People Living with Rheumatic Disease

New study explores what people living with rheumatic and musculoskeletal disease want to know about managing their health.

Creaky StaffBy
6.15.17 2:15PM

Drug shows promising signs for postmenopausal women with osteoporosis

Postmenopausal women with osteoporosis who took romosozumab for a year experienced “rapid and large reductions" in risk of fracturing vertebrae.

Creaky StaffBy
6.14.17 3:24PM

Study: Early pre-RA treatment can curb future disease development

EULAR report highlights the importance of early intervention in the treatment of people with rheumatic and musculoskeletal diseases.